Filed: 5/4/2026ACC: 0000908834-26-000206
📋 What this filing means
ESSEX WOODLANDS MANAGEMENT, INC. filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $250.54M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$250.54M
Total AUM (reported)
51.12M
Total Shares
Allocation by class
COM CL A$118.88M47.5%
COM$116.15M46.4%
COM NEW$15.50M6.2%
Portfolio Concentration
Top 3$244.24M97.5%
4–10$6.30M2.5%
Top 3 weight
97.5%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 51.12M
Sole
Full voting authority
51.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
BIOVENTUS INC
SOLEShares13.02M
TypeSH
Market value$118.88M
47.45%
Sole
13.02M
Shared
0.00
None
0.00
MIMEDX GROUP INC
SOLEShares28.20M
TypeSH
Market value$111.37M
44.45%
Sole
28.20M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.08M
TypeSH
Market value$13.98M
5.58%
Sole
1.08M
Shared
0.00
None
0.00
TELA BIO INC
SOLEShares7.71M
TypeSH
Market value$4.78M
1.91%
Sole
7.71M
Shared
0.00
None
0.00
MEDICINOVA INC
SOLEShares1.11M
TypeSH
Market value$1.52M
0.60%
Sole
1.11M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BIOVENTUS INCSOLE | COM CL A | 13.02M | SH | $118.88M 47.45% | 13.02M | 0.00 | 0.00 |
MIMEDX GROUP INCSOLE | COM | 28.20M | SH | $111.37M 44.45% | 28.20M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.08M | SH | $13.98M 5.58% | 1.08M | 0.00 | 0.00 |
TELA BIO INCSOLE | COM | 7.71M | SH | $4.78M 1.91% | 7.71M | 0.00 | 0.00 |
MEDICINOVA INCSOLE | COM NEW | 1.11M | SH | $1.52M 0.60% | 1.11M | 0.00 | 0.00 |